Upamostat

DB13052InvestigationalSmall molecule

Upamostat has been used in trials studying the treatment of Pancreatic Cancer.

Chemical structure of Upamostat
Formula / weight
C32H47N5O6S · 629.82 g/mol (avg)
Also known as
Mesupron
Code names
WX-671

Resolves to

Compound
UNIIS5M7KW6U17CAS1191101-18-4PubChem9852201
Structure
InChIKeyHUASEDVYRABWCV-NDEPHWFRSA-NSMILESCCOC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(\N)=N/O)NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C
Targets
P00749PLAU

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Upamostat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In